We are live on
!
Find out more
PA
Pinnacle Associates Portfolio holdings
AUM
$7.78B
1-Year Est. Return
45.07%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$5.12B
AUM Growth
+$288M
(+6%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
21.33%
Holding
608
New
37
Increased
185
Reduced
325
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FWM
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
|
+$26.7M |
| 2 |
Madison Square Garden
MSGS
|
+$11.5M |
| 3 |
ATML
ATMEL CORP
ATML
|
+$9.04M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$6.61M |
| 5 |
BRSL
Brightstar Lottery PLC
BRSL
|
+$6.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$90.6M |
| 2 |
SKS
SAKS INCORPORATED
SKS
|
+$26.5M |
| 3 |
BLC
BELO CORP SER A
BLC
|
+$25.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$12.7M |
| 5 |
Las Vegas Sands
LVS
|
+$3.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.77% |
| 2 | Technology | 12.51% |
| 3 | Healthcare | 12.2% |
| 4 | Communication Services | 11.01% |
| 5 | Consumer Discretionary | 7.21% |
Similar funds
EHC
IMCOOI
PGFC
WRCM
WF
SIAU
BFM
SF
Pinnacle Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Pinnacle Associates held 608 positions worth $5.12B, up 6% from $4.83B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Pinnacle Associates's Q4 2013 filing shows 37 new, 185 increased, 325 reduced and 15 closed positions. Its largest new stake was FAIRWAY GROUP HLDGS CORP CL A COM STK (DE): 1,273,770 shares worth $23.1M. The largest sale was ONYX PHARMACEUTICALS INC, an estimated $90.6M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Pinnacle Associates's largest Q4 2013 buy was FAIRWAY GROUP HLDGS CORP CL A COM STK (DE): 1,273,770 shares worth $23.1M.
- Pinnacle Associates added most to Madison Square Garden in Q4 2013, an estimated $11.5M increase.
- Pinnacle Associates's biggest Q4 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $12.7M.
- Pinnacle Associates fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $90.6M.
- Pinnacle Associates's ten largest holdings make up 21% of its $5.12B portfolio in Q4 2013.
- Pinnacle Associates opened 37 new positions and closed 15 in Q4 2013.
- Pinnacle Associates's portfolio value rose 6% quarter-over-quarter to $5.12B.
Based on Pinnacle Associates's 13F filing for Q4 2013, filed 12 Feb 2014.